Walleye Capital LLC Dyne Therapeutics, Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$23.65 - $35.63 $2.03 Million - $3.05 Million	85,652 New	85,652 $3.02 Million
Q3 2023 Nov 14, 2023	BUY	$8.6 - $12.18 $2.41 Million - $3.41 Million	280,276 New	280,276 $2.51 Million
Q2 2021 Aug 16, 2021	SELL	$15.94 - $22.33 $318,800 - $446,599	-20,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$14.0 - $29.3 $280,000 - $586,000	20,000 New	20,000 $311,000

209

102M

234K

238K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.22B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.